Page 126 - Critical Care Notes
P. 126

4223_Tab03_107-130  29/08/14  8:28 AM  Page 120



                        RESP
          ■ The aims are to decrease pulmonary pressure, remove excessive fluid, and
            decrease the risk of clotting.
          ■ Monitor respiratory, cardiac, and neurological status.
          ■ Institute ECG and hemodynamic monitoring. Administer antiarrhythmics as
            indicated. Cardioversion or radiofrequency ablation may be needed to treat
            atrial fibrillation/flutter. A pulmonary artery catheter (Swan Ganz) is generally
            indicated.
          ■ Provide O 2 therapy: cannula, mask, ventilator. Monitor ABGs. Avoid intubation
            if possible.
          ■ Administer bronchodilators as indicated.
          ■ Consider standby therapeutic phlebotomy if Hct >60%.
          ■ Maintain Hgb to minimum 10 g/dL.
          ■ Provide low-sodium diet and fluid restrictions. Correct fluid and electrolyte
            and acid-base disturbances. Administer diuretics as needed.
          ■ Complex management is needed to maintain adequate preload but avoid
            overfilling RV → compress LV →↓ cardiac output.
          ■ Treat hypotension and low cardiac output as needed.
          ■ The use of calcium channel blockers, steroids, anticoagulation, antiplatelet
            drugs, and endothelin receptor antagonists have been found to be more
            suited for non–critically ill patients with PAH but may be considered for
            critically ill patients as needed. Calcium channel blockers and beta blockers
            should be avoided in the critically ill because they reduce cardiac function.
          ■ Dobutamine preferred if inotropes necessary. Also use of norepinephrine
            preferred.
          ■ Administer digoxin (Lanoxin) as necessary.
          ■ Administer prostanoids: treprostinil (Remodulin, Tyvaso), epoprostenol
            (Flolan), iloprost (Ventavis).
          ■ Administer endothelin-receptor antagonists: bosentan (Tracleer), sitaxsentan
            (Thelin), ambrisentan (Letairis).
          ■ Administer phosphodiesterase type 5 (PDE5) inhibitors: sildenafil (Viagra),
            tadalafil (Cialis), vardenafil (Levitra).
          ■ Treat pulmonary embolism with thrombolytics or anticoagulants as
            appropriate.
          ■ Surgery (optional): atrial septostomy, pulmonary thromboendarterectomy.
          ■ Consider ECMO as a bridge to transplantation.
          ■ Consider lung or heart-lung transplantation because biventricular HF may
            develop.
                         Pulmonary Embolism
          Pulmonary embolism is defined as an obstruction of the pulmonary artery or
          its branch (pulmonary vasculature) by a thrombus or thrombi (blood clot) that
                                                       · ·
          originates in the venous circulatory system or the right side of the heart. A V/Q
          mismatch → hypoxemia and intrapulmonary shunt.
                                120
   121   122   123   124   125   126   127   128   129   130   131